(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-13 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 2489024
Date | Daily Closing Price | Open | High | Low | Volume |
13 Mon Jan 2025 | 0.60 | 0.62 | 0.63 | 0.58 | 0.646 times |
10 Fri Jan 2025 | 0.62 | 0.62 | 0.63 | 0.58 | 0.723 times |
08 Wed Jan 2025 | 0.62 | 0.65 | 0.65 | 0.59 | 0.585 times |
08 Wed Jan 2025 | 0.62 | 0.65 | 0.65 | 0.59 | 0.585 times |
07 Tue Jan 2025 | 0.65 | 0.66 | 0.67 | 0.60 | 0.861 times |
06 Mon Jan 2025 | 0.65 | 0.65 | 0.69 | 0.65 | 0.423 times |
03 Fri Jan 2025 | 0.65 | 0.62 | 0.68 | 0.62 | 1.121 times |
02 Thu Jan 2025 | 0.62 | 0.54 | 0.66 | 0.54 | 0.948 times |
31 Tue Dec 2024 | 0.54 | 0.55 | 0.56 | 0.53 | 1.298 times |
30 Mon Dec 2024 | 0.55 | 0.58 | 0.59 | 0.55 | 1.532 times |
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.53 |
Downside Target | 0.57 |
Upside Target | 0.61 |
Upside Target | 0.63 |
Upside Target | 0.65 |
Upside Target | 0.67 |
Upside Target | 0.68 |
Upside Target | 0.69 |
Upside Target | 0.86 |
Upside Target | 0.87 |
Upside Target | 0.96 |
Upside Target | 1.32 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.58 |
Downside Intraday Target | 0.55 |
Upside Intraday Target | 0.63 |
Upside Intraday Target | 0.65 |
Upside Intraday Target | 0.6 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
13 Mon Jan 2025 | 0.60 | 0.62 | 0.63 | 0.58 | 0.494 times |
10 Fri Jan 2025 | 0.62 | 0.65 | 0.65 | 0.58 | 0.7 times |
08 Wed Jan 2025 | 0.62 | 0.65 | 0.69 | 0.59 | 0.381 times |
03 Fri Jan 2025 | 0.65 | 0.58 | 0.68 | 0.53 | 0.931 times |
27 Fri Dec 2024 | 0.59 | 0.60 | 0.61 | 0.55 | 0.938 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
13 Mon Jan 2025 | 0.60 | 0.54 | 0.69 | 0.54 | 0.307 times |
31 Tue Dec 2024 | 0.54 | 0.65 | 0.67 | 0.53 | 1.108 times |
26 Tue Nov 2024 | 0.68 | 0.73 | 0.86 | 0.57 | 1.613 times |
31 Thu Oct 2024 | 0.73 | 0.94 | 0.96 | 0.67 | 1.299 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.6 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.6 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.